arrow
A

Antonio Bognanni

mcmaster university
H指数:19
被引数:5,455

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Use of Artificial Intelligence-Based Platforms to Support Searches in Evidence Synthesis Studies: A Study of the EAACI Methodology Committee

基于人工智能平台的证据综合研究检索支持应用:EAACI方法学委员会的研究

2026-09-130
OAAI
As-Needed Versus Regular Medication Use in the Treatment of Allergic Rhinitis in the Pollen Season: A MASK-air Study

花粉季节过敏性鼻炎治疗中按需用药与常规用药的比较:一项MASK-air研究

2026-09-100
OAAI
ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases

ARIA-EAACI 2025:气道疾病中以患者为中心、数字化赋能和人工智能辅助的变革管理

2026-09-030
OAAI
Efficacy and safety of oral treatments for allergic rhinitis in children: A network meta-analysis

儿童过敏性鼻炎口服治疗的疗效与安全性:一项网络Meta分析

2026-09-010
PRE
Artificial Intelligence-enabled GRADE: how the GRADE Working Group will use automation to rate the certainty of evidence of intervention effects

人工智能赋能的GRADE:GRADE工作组将如何利用自动化对干预效应的证据确定性进行评级

2026-08-010
PRE
World Allergy Organization (WAO) Consensus on the use and practice of precautionary allergen labelling: The international ACT-UP! e-Delphi

世界过敏组织(WAO)关于预防性过敏原标签使用和实施实践的共识:国际ACT-UP! e-Delphi

2026-08-010
PRE
The GRADE living map: the interactive and living index of GRADE content. A statement by the GRADE guidance group

GRADE实时地图:GRADE内容的交互式实时索引。GRADE指南小组声明

2026-08-011
PRE
Frameworks to identify research gaps, frame research needs, and derive research priorities from evidence syntheses: a scoping review

基于证据综合的研究空白识别框架、研究需求界定框架及研究优先级推导框架:一项范围综述

2026-05-260
PRE
Comparison of Allergic Rhinitis Treatments on Utilities and Quality of Life: A MASK-air Study

过敏性鼻炎治疗方法在效用和生活质量方面的比较:一项MASK-air研究

2026-05-060
OAAI
Trace Elements in Allergy: Narrative Review

过敏中的微量元素:叙事性综述

2026-05-040
OAAI
Treatment Dose Increase Versus Co-Medication in Allergic Rhinitis: Systematic Review With Dose–Response Network Meta-Analysis

过敏性鼻炎的治疗剂量增加与联合用药比较:剂量-反应网络Meta分析的系统性综述

2026-05-010
OAAI
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第II部分—口服和眼部治疗指南

2026-03-240
OAAI
Efficacy and Safety of Oral Antihistamines for Allergic Rhinitis: Network Meta-Analysis

口服抗组胺药治疗过敏性鼻炎的疗效与安全性:网络Meta分析

2026-02-160
OAAI
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第一部分—关于鼻内治疗的指南

2025-12-010
OAAI
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms

过敏性鼻炎及其对哮喘的影响(ARIA)-EAACI 2024–2025指南的开发方法:从证据到决策框架到数字化共享决策算法

2025-11-210
OAAI
Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data

基于移动健康数据,采用目标试验模拟方法评估过敏性鼻炎药物的有效性

2025-11-010
OAAI
Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK-air and EAACI Methodological Committee Report

过敏性鼻炎治疗对患者满意度的影响比较:一项MASK-air和EAACI方法学委员会报告

2025-09-260
OAAI